XML 23 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Revenue $ 4,458,036 $ 4,153,945 $ 3,826,321
Cost of revenue 2,179,824 2,110,015 2,012,744
Gross profit 2,278,212 2,043,930 1,813,577
Operating expenses:      
Research and development 1,008,747 942,790 1,079,081
Sales and marketing 860,821 1,022,985 1,248,032
General and administrative 449,079 468,459 517,414
Restructuring costs 13,273 165,733 76,636
Impairment of long-lived assets 0 320,504 97,722
Total operating expenses 2,331,920 2,920,471 3,018,885
Loss from operations (53,708) (876,541) (1,205,308)
Other expenses, net:      
Share of losses from equity method investment (108,481) (121,897) (35,315)
Impairment of strategic investments (8,220) (46,154) 0
Other income (expenses), net 81,796 47,863 (3,009)
Total other expenses, net (34,905) (120,188) (38,324)
Loss before provision for income taxes (88,613) (996,729) (1,243,632)
Provision for income taxes (20,790) (18,712) (12,513)
Net loss attributable to common stockholders $ (109,403) $ (1,015,441) $ (1,256,145)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.66) $ (5.54) $ (6.86)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.66) $ (5.54) $ (6.86)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 165,925,128 183,327,844 182,994,038
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 165,925,128 183,327,844 182,994,038